언어 선택

PAR2

PAR2 분자 정보

영어 이름	Protease-activated receptor-2	시판 약물 수	0
임상 약물 수	3	표적 별명	Receptor， PAR-2，F2RL1，Thrombin receptor-like 1，G-protein coupled receptor 11，F2R Like Trypsin Receptor 1，PAR2，GPR11，Protease-Activated Receptor 2，Coagulation Factor II (Thrombin) Receptor-Like 1，Proteinase-Activated Receptor-2，Proteinase-activated receptor 2，Coagulation factor II receptor-like 1
최고 연구 개발 단계	Phase 2 Clinical

영어 이름	Protease-activated receptor-2
표적 별명	Receptor， PAR-2，F2RL1，Thrombin receptor-like 1，G-protein coupled receptor 11，F2R Like Trypsin Receptor 1，PAR2，GPR11，Protease-Activated Receptor 2，Coagulation Factor II (Thrombin) Receptor-Like 1，Proteinase-Activated Receptor-2，Proteinase-activated receptor 2，Coagulation factor II receptor-like 1
시판 약물 수	0
임상 약물 수	3
최고 연구 개발 단계	Phase 2 Clinical

PAR2 제품 목록

속성
Protein (1)
제품 라이브러리
온라인 (1)
종
Human (1)
태그
- (1)
마커
Unconjugated (1)

제품 번호	종	발현 시스템	제품 설명	단백질 구조	순도	특성
PA2-H52P7	Human	HEK293	Human PAR2 Full Length Protein (VLP)

총 수량1

PAR2분자 배경

This gene encodes a member of the G-protein coupled receptor 1 family of proteins. The encoded cell surface receptor is activated through proteolytic cleavage of its extracellular amino terminus, resulting in a new amino terminus that acts as a tethered ligand that binds to an extracellular loop domain. Activation of the receptor has been shown to stimulate vascular smooth muscle relaxation, dilate blood vessels, increase blood flow, and lower blood pressure. This protein is also important in the inflammatory response, as well as innate and adaptive immunity. [provided by RefSeq, Jun 2016]

PAR2분자 별명

PAR2

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
MEDI-0618	MEDI-0618; MEDI0618; ABBV-2002; ABBV2002	Phase 2 Clinical	Astrazeneca Plc	Chronic Pain; Migraine Disorders	상세
TEV-56192	TEV-56192	Phase 1 Clinical	Teva Pharmaceutical Industries Ltd	Nervous System Diseases	상세
OA-235i	OA-235i	Phase 1 Clinical	Oasis Pharmaceuticals LLC	Metabolic Dysfunction-Associated Steatotic Liver Disease	상세